These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22518841)

  • 41. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
    J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM
    Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
    [No Abstract]   [Full Text] [Related]  

  • 44. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
    Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
    J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).
    Bexborn F; Andersson PO; Chen H; Nilsson B; Ekdahl KN
    Mol Immunol; 2008 Apr; 45(8):2370-9. PubMed ID: 18096230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.
    Daha MR; Deelder AM; Van Es LA
    J Immunol; 1984 May; 132(5):2538-42. PubMed ID: 6232321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decay acceleration of the complement alternative pathway C3 convertase.
    Hourcade DE; Mitchell LM; Medof ME
    Immunopharmacology; 1999 May; 42(1-3):167-73. PubMed ID: 10408377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK; Müller-Eberhard HJ
    J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1971-5. PubMed ID: 273923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I; Fujita T; Nussenzweig V
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of the formation of the human amplification C3 convertase of complement by polycations.
    Maillet F; Kazatchkine MD
    Immunology; 1983 Sep; 50(1):27-33. PubMed ID: 6554235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.
    Pedersen DV; Gadeberg TAF; Thomas C; Wang Y; Joram N; Jensen RK; Mazarakis SMM; Revel M; El Sissy C; Petersen SV; Lindorff-Larsen K; Thiel S; Laursen NS; Fremeaux-Bacchi V; Andersen GR
    Front Immunol; 2019; 10():2007. PubMed ID: 31507604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
    Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
    Front Immunol; 2018; 9():1691. PubMed ID: 30083158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional and structural insight into properdin control of complement alternative pathway amplification.
    Pedersen DV; Roumenina L; Jensen RK; Gadeberg TA; Marinozzi C; Picard C; Rybkine T; Thiel S; Sørensen UB; Stover C; Fremeaux-Bacchi V; Andersen GR
    EMBO J; 2017 Apr; 36(8):1084-1099. PubMed ID: 28264884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
    Pangburn MK; Müller-Eberhard HJ
    Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Parker CJ; Baker PJ; Rosse WF
    J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Sez6 Family Inhibits Complement by Facilitating Factor I Cleavage of C3b and Accelerating the Decay of C3 Convertases.
    Qiu WQ; Luo S; Ma SA; Saminathan P; Li H; Gunnersen JM; Gelbard HA; Hammond JW
    Front Immunol; 2021; 12():607641. PubMed ID: 33936031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.